Introducing Ro’s GLP-1 Supply Tracker – a free, open access tool to help patients and providers find out which medications are available (and where) and which aren’t. https://lnkd.in/en5qTGAa We built this tracker to give patients an easier way to navigate GLP-1 shortages, by: 1️⃣ Clearly showing which GLP-1s are currently in shortage by drug and dose 2️⃣ Making it easy for everyone to crowdsource where and when they find GLP-1 supply or, when they cannot, to submit a shortage report to the FDA 3️⃣ Letting anyone join our “Supply List” that sends real-time alerts when GLP-1 supply is located at a pharmacy near them 4️⃣ Sending automated notifications to patients and providers who sign-up letting them know when a drug’s status changes on the FDA’s list. Our hope is that this tracker will help ease the burden that drug shortages have placed on patients and providers, and increase access to these life-changing treatments.
Ro
Hospitals and Health Care
New York, NY 51,301 followers
Our mission is to help patients achieve health goals by delivering the most convenient and effective care possible.
About us
Ro is a direct-to-patient healthcare company providing high-quality, affordable healthcare without the need for insurance. Ro is the only company to seamlessly connect telehealth and in-home care, diagnostics, labs, and pharmacy services nationwide. This is enabled by Ro’s vertically integrated platform that powers a personalized, end-to-end healthcare experience from diagnosis, to delivery of medication, to ongoing care. Since 2017, Ro has facilitated more than eight million digital healthcare visits in nearly every county in the United States, including 98% of primary care deserts. Ro also provides its patient-centric solutions including Workpath, its in-home care API, and Kit, its at-home diagnostic testing service, to other healthcare companies.
- Website
-
https://ro.co
External link for Ro
- Industry
- Hospitals and Health Care
- Company size
- 201-500 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2017
Locations
-
Primary
625 6th Ave
New York, NY 10011, US
Employees at Ro
Updates
-
We’re excited to see our patient, Danielle, featured in Verywell Mind, where she shares her experience with food noise. https://lnkd.in/ekFRsrxd Since beginning GLP-1 treatment with Ro, Danielle has found relief from food noise, allowing her to focus on what matters most: quality time with her family. Now, she’s enjoying moments like coaching her son’s basketball team and fun date nights with her husband.
-
"At Ro, we believe in a strong attract, strong repel culture. It’s a self-selecting group that deeply believes in a shared set of principles." Congratulations to Ro CEO Zachariah Reitano for being named one of Reuters' Future Leaders in Healthcare. You can download the full report here: https://lnkd.in/eGdjzgCU
-
What are the best ways to maintain muscle while on GLP-1s? In part 2 of our series, Ro advisors, David Allison and Beverly Tchang, along with Ro’ers, Raoul Manalac and Lauren Broffman, PhD, discuss the relationship between weight loss and muscle mass and strength. Read their insights on maintaining both with lifestyle interventions alongside treatment with GLP-1 medications here: https://lnkd.in/dZ_Tdyz2
How can people maintain muscle tissue and function alongside GLP-1 medications?
ro.co
-
Curious about how anti-Müllerian hormone (AMH) levels impact fertility? Our latest research, published in the Journal of Fertility and Sterility, offers the largest cohort study to date on how AMH levels impact natural conception. These findings can provide valuable insights for patients and healthcare providers when making informed decisions about family planning. Want to know more? Read the full blog for a closer look at the study and what the findings mean: https://lnkd.in/dC5GA9VY #Fertility #ReproductiveHealth #HealthcareResearch #FamilyPlanning #AMH
-
We’re honored to announce that Ro has been named one of Fortune's Best Workplace in Health Care for the fourth consecutive year! 🎉https://lnkd.in/eETkSQq5 Thank you to our entire team for your commitment to making a meaningful impact on patients’ lives and for creating a workplace where innovation, compassion, and collaboration thrive. Together, we’re helping patients achieve their health goals by delivering the easiest, most effective care possible. 💪 #LifeAtRo #GPTW #Healthcare #BestWorkplaces
Fortune Best Workplaces in Health Care™ 2024
greatplacetowork.com
-
Ro makes Certificates of Analysis (CoA) available to any patient prescribed a compounded GLP-1. As part of our extensive quality control and assurance measures, Ro uses a third-party lab to conduct independent testing on each batch of compounded GLP-1s. Our team reviews all the results to ensure each batch of medication passes all of the testing, and we believe patients should have access to this information too. Learn more about what Ro's CoAs include and how the information can help patients confirm the quality of their medication: https://lnkd.in/gV3TSsHD
Commitment to Quality: Ro’s Certificates of Analysis for Compounded GLP-1s
ro.co
-
What’s going on with the GLP-1 drug shortages? Since introducing our GLP-1 Supply Tracker three months ago, we've received over 60,000 drug shortage reports from patients nationwide. What does this data reveal? GLP-1s indicated for weight loss make up the vast majority of shortage reports, especially the lower doses of Wegovy and Zepbound. Dive into our latest blog to read more insights, including: ➡️ First-hand challenges patients are facing filling their prescriptions; ➡️ The latest updates from pharma companies and the FDA; ➡️ How recent trends in Tracker data point to some signs of GLP-1 supply progress. Check it out here: https://lnkd.in/gDiEjBnP
Taking Stock: What Ro's GLP-1 Supply Tracker Reveals about the Drug Shortages
ro.co